
Novartis maintains growth momentum and confirms FY’22 Group guidance
Ad hoc announcement pursuant to Art. 53 LR Q3 sales grew +4% cc1 (-4% USD) Innovative Medicines (IM) sales grew +4% cc (-3% USD), driven […]
Ad hoc announcement pursuant to Art. 53 LR Q3 sales grew +4% cc1 (-4% USD) Innovative Medicines (IM) sales grew +4% cc (-3% USD), driven […]
Today, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specifies what additional data must be reported to HHS by laboratories […]
Today, the European Centre for Disease Prevention and Control (ECDC) published guidance to Member States for the development of COVID-19 surveillance in long-term care facilities. […]
Today, the Commission presents a package of guidelines and recommendations to help Member States gradually lift travel restrictions and allow tourism businesses to reopen, after […]
The European Commission has published detailed guidance on how coronavirus-related humanitarian aid can be sent to countries and areas around the world that are subject […]
Today, the Commission has published guidance to ensure that clinical trials can continue taking place in the EU during the coronavirus pandemic. The aim is […]
The European Agency for Safety and Health at Work (EU-OSHA)has issued today guidance on coming back to work after coronavirus. The European Commission attaches the […]
The Commission has published guidance on the development of new apps that support the fight against coronavirus in relation to data protection. The development of […]
Plasma transfusion is a potentially promising therapy for COVID-19 patients that can be made widely available at relatively short notice by blood services across the […]
Blood, tissues, cells and organs / COVID-19 as PDF download ECDC guidance document on COVID-19 and Substances of Human Origin (SoHO) https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-supply-substances-human-origin.pdf © European Centre […]
Copyright © 2023 | WordPress Theme by MH Themes